Posted: 19 Jun. 2024 5 min. read

Investment expectations for emerging technology markets in the year ahead

By Heather Gates, Managing Director, Audit & Assurance Private Growth Leader, Deloitte & Touche LLP, and Bill Carey, Partner, Greater Tri-state EGC and Health Tech Leader, Deloitte & Touche LLP

Talking points
  • Recent trends have driven an uptick in venture funding for expansion-stage technology companies compared to other emerging growth companies (EGCs) in 2024.
  • These trends include a willingness among investors to pay for rapid growth if liquidity and profitability look strong, and a preference for tech sectors with a greater potential for exits.
  • Deloitte’s latest Road to Next publication provides an in-depth look at these trends, which we’ve also summarized below.

An abundance of caution has dampened EGC venture funding over the past two years. But one segment has bucked the trend: expansion-stage tech companies. This select group of EGCs, which are still privately held and include investments from institutional funds, are some of the fastest-growing, most innovative verticals in the tech space. In the first quarter of 2024, the value of expansion-stage tech company venture investments increased substantially to $18.1 billion (from $14 billion in Q4 2023), with the number of deals exceeding 300.

What’s behind this resurgence of expansion-stage tech startups compared to other EGCs? And what trends will affect funding prospects moving forward? The answers to both are explored in Deloitte’s new Road to Next thought piece that can help explain the near-term outlook for EGC funding. Let’s break down some of the findings. 

The importance of liquidity

Liquidity continues to be a major concern for EGC tech investors. A decline in EGC liquidity in 2022 and 2023 decreased the number of exits during that period from the 2021 peak. As a result, investors have upped their focus on liquidity, leading to an increase in exits in expansion-stage technology so far in 2024.

The data shows that buyouts and strategic acquisitions make up the bulk of Q1 2024 exits, while some additional liquidity is also generated by secondary-market transactions. With the cost of capital still high compared to the past, valuations have decreased to more reasonable levels. The result? Transactions are currently more appropriately priced, so more corporate development and late-stage investment teams are now considering them. 

The shift to profitability

Closely related to liquidity is profitability. Over the past two years, concerns over liquidity and exit potential have shifted the negotiating advantage in venture deals toward investors. What does this shift mean for expansion-stage EGCs? It means there is now a distinct emphasis on transitioning from growth at any cost to prioritizing profitability. As a result, companies with clear profitability in their direct line of sight now have a fundraising advantage. That’s why we can expect proven profitability to move higher on the EGC tech companies’ agenda over the next 12 months.

Preferred tech sectors

When it comes to investment decisions, not all tech segments are created equal. Those focused on technology innovation have garnered the lion’s share of venture funding based largely on exit potential. The artificial intelligence (AI) and machine learning (ML) segment has led the charge with the largest deal value so far in 2024, followed by digital health, robotics and drones, agriculture tech (AgTech), and insurance tech (InsurTech). Not surprisingly, these markets have seen the largest uptick in liquidity, leading to a general flattening of this metric compared to the volatility of the past two years. While these trends could easily reverse, at present they are driving the near-term funding market.

What role can Deloitte play?

Want to learn more about these EGC tech funding trends? Read Road to Next, our quarterly report on emerging investment trends in private financial markets and the venture capital ecosystem. Deloitte understands the value and long-term investment potential in technology companies and can provide a wide range of audit and assurance solutions. Don’t hesitate to reach out to either of us with any thoughts or questions.

This publication contains general information only and Deloitte is not, by means of this publication, rendering accounting, business, financial, investment, legal, tax, or other professional advice or services. This publication is not a substitute for such professional advice or services, nor should it be used as a basis for any decision or action that may affect your business. Before making any decision or taking any action that may affect your business, you should consult a qualified professional advisor. Deloitte shall not be responsible for any loss sustained by any person who relies on this publication.

Over the past two years, concerns over liquidity and exit potential have shifted the negotiating advantage in venture deals toward investors. What does this shift mean for expansion-stage EGCs? It means there is now a distinct emphasis on transitioning from growth at any cost to prioritizing profitability.

Subscribe to receive The Pulse

 

Get in touch

Heather Gates
Managing Director, Audit &
Assurance Private Growth Leader
Deloitte & Touche LLP
+1 408 704 4414
hgates@deloitte.com

  

Bill Carey
Partner, Greater Tri-state
EGC and Health Tech Leader
Deloitte & Touche LLP
+1 973-602-6343
wcarey@deloitte.com